◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksEQNR › Revenue

Equinor ASA ADR (EQNR) Revenue 2006–TTM

DATA UPDATED 2026-07-19

Equinor ASA ADR annual revenue for fiscal TTM was $104.2 billion, a decrease of 1.8% from $106.2 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

EQNR Annual Revenue

Revenue (annual)TTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$104.2B$106.2B$102.5B$106.8B$149.0B$88.7B$45.8B$62.9B$78.8B$61.0B$45.7B$57.6B$96.2B$104.9B$121.0B$115.2B$87.1B$73.5B$115.5B$90.7B$80.9B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EQNR Quarterly Revenue

Revenue (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$27.8B$25.3B$26.0B$25.1B$29.4B$26.5B$25.4B$25.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More EQNR metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All EQNR financial statements → Interactive EQNR charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.